A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 34; no. 5; pp. 1767 - 1770
Main Authors Gossmann, J, Mondorf, U, Dietz, A, Kramer, W, Kachel, H.-G, Geiger, H, Scheuermann, E.-H
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.08.2002
Elsevier Science
Subjects
Adult
Biological and medical sciences
Blood Pressure - drug effects
Calcium Channel Blockers - therapeutic use
Creatinine - blood
Cyclosporine - blood
Cyclosporine - therapeutic use
Double-Blind Method
Gallopamil - therapeutic use
Humans
Immunomodulators
Immunosuppressive Agents - blood
Immunosuppressive Agents - therapeutic use
Kidney Transplantation - physiology
Medical sciences
Pharmacology. Drug treatments
Placebos
Prospective Studies
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Urea - blood
Uric Acid - blood
Verapamil - therapeutic use
Human
Drug combination
Gallopamil
Treatment efficiency
Calcium antagonist
Controlled therapeutic trial
Transplantation
Homotransplantation
Kidney
Prospective
Prevention
Chemotherapy
Treatment
Urinary system
Surgery
Placebo
Aralkylamine
Double blind study
Graft
Ciclosporin
Immunosuppressive agent
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(02)03059-2